HCSG
Healthcare Services Group Inc: Expects Mid-Single Digit Revenue Growth in 2025 and Q1 Revenue in Range of $440.0 to $450.0 Mln
时间：2025-02-12 20:08:42 市场： 美股 综合
Healthcare Services Group Q4 Net Income USD 11.92 Million
时间：2025-02-12 20:00:02 市场： 美股 综合
Hcsg Reports Q3 2024 Results
时间：2024-10-23 19:00:02 市场： 综合 美股
Healthcare Services Group - Does Not Believe Cybersecurity Incident Will Have a Material Effect on Its Financial Condition or Results of Operations
时间：2024-10-17 05:08:06 市场： 美股 综合
Healthcare Services Group - on October 9 Identified a Cybersecurity Incident
时间：2024-10-17 05:08:06 市场： 美股 综合
Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys Proteomics International Laboratories (ASX:PIQ) investors are left with "considerable unknowns" after the medical technology business terminated its exclusive license with Sonic Healthcare USA for its PromarkerD kidney disease diagnostic tool, according to a Wednesday note from Euroz Hartleys.The license was canceled after certain milestones were not met, with the US launch now slated for 2025, targeting alternative pathology labs and service providers, and direct to consumers and patients.While Proteomics has partners for Europe and other territories for PromarkerD, not commercializing in the US healthcare market, the world's largest, has lost potentially 32 million patients and potential users of the test, the investment firm said.Euroz Hartleys downgraded Proteomics to hold from speculative buy and lowered the price target to AU$0.73 price target from AU$1.10 on increased
时间：2024-09-13 06:17:48 市场： 综合 美股
Community Health Systems Says Chief Medical Officer to Retire Community Health Systems (CYH) said Wednesday that Lynn Simon, president of Healthcare Innovation and chief medical officer, will retire from her executive position at the end of the year and transition into a consulting arrangement from Jan. 1, 2025.Under her consulting agreement, Simon will advise the company's management team on healthcare innovation and also help identify and facilitate new partnerships, the firm said.Miguel Benet, executive vice president of clinical operations, will become the company's president of clinical operations and chief medical officer from next year, the company said.Price: 5.57, Change: +0.05, Percent Change: +0.91
时间：2024-09-12 05:42:36 市场： 美股 综合
Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit Proteomics International Laboratories (ASX:PIQ) issued a notice of termination to Sonic Healthcare USA, the US distributor of its diabetic kidney disease test PromarkerD, effective Tuesday, after not meeting certain milestones to commercialize the test kit, according to a Wednesday filing with the Australian bourse.Following the termination, the diagnostic firm will now market and sell PromarkerD in the US via licensing deals with service providers, pathology laboratories, and/or direct-to-consumer/patient channels, the filing said.The company will establish a code-compliant third-party reference laboratory ahead of the test kit's launch, the filing stated.
时间：2024-09-11 07:59:31 市场： 美股 综合